These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25358377)

  • 1. Augmentation of antipsychotics with electroconvulsive therapy in treatment-resistant schizophrenia patients with dominant negative symptoms: a pilot study of effectiveness.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Neuropsychobiology; 2014; 70(3):158-64. PubMed ID: 25358377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Psychiatry Res; 2014 Dec; 220(1-2):175-80. PubMed ID: 25129562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial.
    Tang WK; Ungvari GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):373-9. PubMed ID: 12691772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Electroconvulsive Therapy Augmentation of Antipsychotic Treatment on Cognitive Functions in Patients With Treatment-Resistant Schizophrenia.
    Vuksan Ćusa B; Klepac N; Jakšić N; Bradaš Z; Božičević M; Palac N; Šagud M
    J ECT; 2018 Mar; 34(1):31-34. PubMed ID: 29053485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECT augmentation of antipsychotics in severely ill schizophrenia: a naturalistic, observational study.
    Usta Saglam NG; Aksoy Poyraz C; Yalcin M; Balcioglu I
    Int J Psychiatry Clin Pract; 2020 Nov; 24(4):392-397. PubMed ID: 32538214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a decline in cognitive functions after combined electroconvulsive therapy and antipsychotic therapy in treatment-refractory schizophrenia?
    Pawełczyk A; Kołodziej-Kowalska E; Pawełczyk T; Rabe-Jabłońska J
    J Nerv Ment Dis; 2015 Mar; 203(3):182-6. PubMed ID: 25668655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.
    Petrides G; Malur C; Braga RJ; Bailine SH; Schooler NR; Malhotra AK; Kane JM; Sanghani S; Goldberg TE; John M; Mendelowitz A
    Am J Psychiatry; 2015 Jan; 172(1):52-8. PubMed ID: 25157964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia.
    Melzer-Ribeiro DL; Napolitano IC; Leite SA; Alencar de Souza JA; Vizzotto ADB; Di Sarno ES; Fortes M; Gomes ML; de Oliveira GM; Avrichir BS; Talib LL; Correll CU; Elkis H
    Schizophr Res; 2024 Jun; 268():252-260. PubMed ID: 38151432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: is it a safe and effective combination?
    Flamarique I; Castro-Fornieles J; Garrido JM; de la Serna E; Pons A; Bernardo M; Baeza I
    J Clin Psychopharmacol; 2012 Dec; 32(6):756-66. PubMed ID: 23131877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness of electroconvulsive therapy in adolescents with schizophrenia spectrum disorders.
    Flamarique I; Baeza I; de la Serna E; Pons A; Bernardo M; Castro-Fornieles J
    Eur Child Adolesc Psychiatry; 2015 May; 24(5):517-24. PubMed ID: 25183368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in positive and negative symptoms, general psychopathology in schizophrenic patients during augmentation of antipsychotics with glycine: a preliminary 10-week open-label study].
    Strzelecki D; Rabe-Jabłońska J
    Psychiatr Pol; 2011; 45(6):825-37. PubMed ID: 22335126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose lamotrigine augmentation therapy improves residual symptoms in treatment-resistant schizophrenia: a report of five cases.
    Ohnuma T; Takebayashi Y; Higashiyama R; Shibata N; Arai H
    Asia Pac Psychiatry; 2013 Dec; 5(4):336-43. PubMed ID: 24591092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
    Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor serum levels in treatment-resistant schizophrenic patients following electroconvulsive therapy.
    Pacitti F; Bersani G; Aloe L; Caredda M; Orsi P; Quartini A; Vitali M; Ceccanti M; Tirassa P; Fiore M; Iannitelli A
    Clin Ter; 2021; 171(1):e67-e74. PubMed ID: 33346332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes.
    Biedermann F; Pfaffenberger N; Baumgartner S; Kemmler G; Fleischhacker WW; Hofer A
    J ECT; 2011 Dec; 27(4):e61-2. PubMed ID: 22124226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia: A Pilot Study.
    Braga RJ; John M; Schooler NR; Bailine SH; Malur C; Mendelowitz A; Petrides G
    J ECT; 2019 Sep; 35(3):156-160. PubMed ID: 30973454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant schizophrenia.
    Ravanić DB; Pantović MM; Milovanović DR; Dukić-Dejanović S; Janjić V; Ignjatović DR; Jović SD; Jurisić V; Jevtović I
    Psychiatr Danub; 2009 Jun; 21(2):179-86. PubMed ID: 19556946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.